Cannabinoid Edible Oil Formulation for Therapeutic Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current edible oils do not effectively address joint, muscle, and tendon soreness, insomnia, sexual arousal, weight loss, pain, and abdominal discomfort due to the lack of specific cannabinoid concentrations and combinations.
Innovation Solution
A method of creating an edible oil composition comprising specific concentrations of cannabigerol (CBG), cannabidiol (CBD), cannabidivarin (CBDV), and THC-O-acetate, extracted and distilled from cannabis flowers, which are then mixed into edible oils to achieve therapeutic effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional edible oils are used, then the product is simple and easy to manufacture, but it does not effectively address joint, muscle, and tendon soreness, insomnia, pain, and other therapeutic needs
Solution Approach 1:
The patent creates a composite cannabinoid formulation containing multiple specific cannabinoids (CBG, CBD, CBDV, and THC-O-acetate) at defined concentrations. This composite approach combines the therapeutic benefits of each cannabinoid to achieve enhanced and reliable therapeutic effectiveness for multiple conditions including joint soreness, muscle pain, insomnia, and abdominal discomfort, while maintaining a standardized composition that can be consistently manufactured.
Solution Approach 2:
The patent specifies precise concentration parameters for each cannabinoid component (CBG: 32-50 mg/ml, CBD: >32 mg/ml, CBDV: 20-50 mg/ml, THC-O-acetate: 32-50 mg/ml). By controlling these chemical concentration parameters within defined ranges, the formulation achieves reliable therapeutic effectiveness while maintaining manufacturability through clear specification of target concentrations.
2Reliability
If multiple cannabinoids are extracted and distilled from different cannabis flowers, then the therapeutic effectiveness is improved, but the manufacturing process becomes more complex
Solution Approach 1:
The patent divides the manufacturing process into separate extraction and distillation steps for each individual cannabinoid (CBG from CBG-enriched flower, CBD from CBD-enriched flower, CBDV from CBDV-enriched flower). This segmentation allows each cannabinoid to be purified independently to high concentrations (75-92% purity), which simplifies the final formulation step where precise amounts of each pure component are combined to achieve the target concentrations in the edible oil.
Solution Approach 2:
The patent performs preliminary extraction and distillation of each cannabinoid from enriched cannabis flowers before final formulation. By pre-purifying CBG, CBD, and CBDV to high concentrations (75-92% purity) through separate distillation processes, the formulation step becomes simpler and more reliable, as the cannabinoids are already in a concentrated, pure state ready for precise dosing in the final edible oil product.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively reduces joint and muscle soreness, improves sleep, increases sexual arousal, aids in weight loss, and alleviates pain and abdominal discomfort when administered in specific dosages.
Implementation Method 1
extracting: (a) CBG from a cannabis Flower enriched in CBG to attain a crude oil CBG extract
Implementation Method 2
distilling: (a) the CBG extract to attain a CBG distillate comprising from about 75% up to about 92% CBG by weight
Data Source
AI summary
Disclosed herein is at least one cannabinoid formulation and at least one method of using a formulation disclosed herein including at least one pharmaceutical use. Further disclosed herein are methods of making at least one cannabinoid disclosed herein.